DRUG Bright Minds Biosciences Inc

54.23

-1.98 (-3.52%)

18 Dec 2024 - Closed

Delayed by 15 minutes

Share Name	Share Symbol	Market	Type
Bright Minds Biosciences Inc	CSE:DRUG	CSE	Common Stock

	Price Change	% Change	Share Price	Bid Price	Offer Price	High Price	Low Price	Open Price	Shares Traded	Last Trade
	-1.98	-3.52%	54.23	54.57	75.00	60.48	54.23	56.77	1,312	21:00:00

Dragon Pharma Announces Results of 2009 Annual General Meeting

22/06/2009 6:11pm

PR Newswire (US)

Bright Minds Biosciences (CSE:DRUG)
Historical Stock Chart

From Dec 2019 to Dec 2024

Click Here for more Bright Minds Biosciences Charts.

VANCOUVER, June 22 /PRNewswire-FirstCall/ -- Dragon Pharmaceutical Inc. ("Dragon Pharma" or the "Company" TSX: DDD; OTCBB: DRUG; BBSE: DRP), a leading international pharmaceutical company, today announced the results of the Annual Shareholders Meeting held on June 21, 2009 in Hong Kong, China. There were 50,209,377 shares equaling 74.87% of the outstanding shares represented at this meeting. The shareholders re-elected the following eight persons to serve as members of the Board of Directors for the Company: Mr. Yanlin Han, Mr. Zhanguo Weng, Ms. Xuemei Liu, Dr. Alexander Wick, Ph.D., Dr. Yiu Kwong Sun, M.D., Mr. Peter Mak, Dr. Heinz Frey and Dr. Jin Li. DATASOURCE: Dragon Pharmaceutical Inc. CONTACT: Dragon Pharmaceutical Inc., Maggie Deng, COO, Telephone: (604) 669-8817, or North America Toll Free: 1-877-388-3784, Email: , Website: http://www.dragonpharma.com/